<?xml version="1.0" encoding="UTF-8"?><ns2:edgarSubmission xmlns:com="http://www.sec.gov/edgar/common" xmlns:ns2="http://www.sec.gov/edgar/ownership">
    <ns2:headerData>
        <ns2:submissionType>144</ns2:submissionType>
        <ns2:filerInfo>
            <ns2:filer>
                <ns2:filerCredentials>
                    <ns2:cik>1766000</ns2:cik>
                    <ns2:ccc>XXXXXXXX</ns2:ccc>
                </ns2:filerCredentials>
            </ns2:filer>
            <ns2:liveTestFlag>LIVE</ns2:liveTestFlag>



        </ns2:filerInfo>
    </ns2:headerData>
    <ns2:formData>
        <ns2:issuerInfo>
            <ns2:issuerCik>0001725123</ns2:issuerCik>
            <ns2:issuerName>Cango Inc.</ns2:issuerName>
            <ns2:secFileNumber>001-38590</ns2:secFileNumber>
            <ns2:issuerAddress>
                <com:street1>18F, Building 3, Youyou Centur</com:street1>
                <com:street2>Plaza, 428 South Yanggao Road</com:street2>
                <com:city>Pudong</com:city>
                <com:stateOrCountry>F4</com:stateOrCountry>
                <com:zipCode>200000</com:zipCode>
            </ns2:issuerAddress>
            <ns2:issuerContactPhone>86-21-3183-5088</ns2:issuerContactPhone>
            <ns2:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Jiayuan Lin</ns2:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <ns2:relationshipsToIssuer>
                <ns2:relationshipToIssuer>Director</ns2:relationshipToIssuer>
            </ns2:relationshipsToIssuer>
        </ns2:issuerInfo>
        <ns2:securitiesInformation>
            <ns2:securitiesClassTitle>ADS</ns2:securitiesClassTitle>
            <ns2:brokerOrMarketmakerDetails>
                <ns2:name>Goldman Sachs &amp; Co. LLC</ns2:name>
                <ns2:address>
                    <com:street1>200 West Street</com:street1>
                    <com:city>New York</com:city>
                    <com:stateOrCountry>NY</com:stateOrCountry>
                    <com:zipCode>10282</com:zipCode>
                </ns2:address>
            </ns2:brokerOrMarketmakerDetails>
            <ns2:noOfUnitsSold>1370803</ns2:noOfUnitsSold>
            <ns2:aggregateMarketValue>10966424</ns2:aggregateMarketValue>
            <ns2:noOfUnitsOutstanding>98262644</ns2:noOfUnitsOutstanding>
            <ns2:approxSaleDate>12/19/2024</ns2:approxSaleDate>
            <ns2:securitiesExchangeName>NYSE</ns2:securitiesExchangeName>
        </ns2:securitiesInformation>
        <ns2:securitiesToBeSold>
            <ns2:securitiesClassTitle>ADS</ns2:securitiesClassTitle>
            <ns2:acquiredDate>09/14/2020</ns2:acquiredDate>
            <ns2:natureOfAcquisitionTransaction>Acquired Class B common shares from Issuer in private transaction; Class B common shares to be converted to Class A common shares in connection with any sales</ns2:natureOfAcquisitionTransaction>
            <ns2:nameOfPersonfromWhomAcquired>Medway Brilliant Holding Limited</ns2:nameOfPersonfromWhomAcquired>
            <ns2:isGiftTransaction>N</ns2:isGiftTransaction>
            <ns2:amountOfSecuritiesAcquired>370803</ns2:amountOfSecuritiesAcquired>
            <ns2:paymentDate>09/14/2020</ns2:paymentDate>
            <ns2:natureOfPayment>None</ns2:natureOfPayment>
        </ns2:securitiesToBeSold>
        <ns2:securitiesToBeSold>
            <ns2:securitiesClassTitle>ADS</ns2:securitiesClassTitle>
            <ns2:acquiredDate>12/27/2019</ns2:acquiredDate>
            <ns2:natureOfAcquisitionTransaction>Acquired Class B common shares from Issuer in private transaction; Class B common shares to be converted to Class A common shares in connection with any sales</ns2:natureOfAcquisitionTransaction>
            <ns2:nameOfPersonfromWhomAcquired>Medway Brilliant Holding Limited</ns2:nameOfPersonfromWhomAcquired>
            <ns2:isGiftTransaction>N</ns2:isGiftTransaction>
            <ns2:amountOfSecuritiesAcquired>1000000</ns2:amountOfSecuritiesAcquired>
            <ns2:paymentDate>12/27/2019</ns2:paymentDate>
            <ns2:natureOfPayment>None</ns2:natureOfPayment>
        </ns2:securitiesToBeSold>
        <ns2:nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</ns2:nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <ns2:noticeSignature>
            <ns2:noticeDate>12/19/2024</ns2:noticeDate>
            <ns2:planAdoptionDates/>
            <ns2:signature>Goldman Sachs &amp; Co. LLC on behalf of Jiayuan Lin</ns2:signature>
        </ns2:noticeSignature>
    </ns2:formData>
</ns2:edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4538}]
144
1766000
XXXXXXXX
LIVE
0001725123
Cango Inc.
001-38590
18F, Building 3, Youyou Centur
Plaza, 428 South Yanggao Road
Pudong
F4
200000
86-21-3183-5088
Jiayuan Lin
Director
ADS
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
1370803
10966424
98262644
12/19/2024
NYSE
ADS
09/14/2020
Acquired Class B common shares from Issuer in private transaction; Class B common shares to be converted to Class A common shares in connection with any sales
Medway Brilliant Holding Limited
N
370803
09/14/2020
None
ADS
12/27/2019
Acquired Class B common shares from Issuer in private transaction; Class B common shares to be converted to Class A common shares in connection with any sales
Medway Brilliant Holding Limited
N
1000000
12/27/2019
None
Y
12/19/2024
Goldman Sachs & Co. LLC on behalf of Jiayuan Lin